| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |